Medicared For All Logo

Sheryl Mulder NP in Ottumwa, Iowa

Home Iowa Ottumwa

Sheryl Mulder NP has Nurse Practitioner as her primary medical specialty. Their primary office is: 1005 Pennsylvania Ave in Ottumwa, Iowa.

They're a part of the: Forefront Dermatology medical group which has around 467 members. You can call their office at 641-683-3195 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 1998 (around 26 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Sheryl A Mulder NP Office Phone and Directions

Sheryl Mulder NP
Forefront Dermatology
1005 Pennsylvania Ave
Ottumwa, Iowa 52501
641-683-3195

Patient Ratings
Please rate your experience with Sheryl Mulder NP below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 641-683-3195


Enter a starting address:


Healthcare Info for Sheryl Mulder NP

Medical School: Sorry, her university is not listed
Graduation Year: 1998
The Primary Medical Specialty for Sheryl Mulder NP is listed as: Nurse Practitioner
Credentials: NP
Additional Credentials:
Approximate Years of Experience: 26
PAC (PECOS ID)#: 7315922036
NPI #: 1962497438
NPI Created On: 09/12/2005
NPI Last Updated Listed as: 02/23/2021
Primary Taxonomy Code: 163W00000X
License Number:
074290
Listed Gender: Female

Procedures, Services, Charges

Services and Procedures include:

  1. Acne surgery
  2. Tangential biopsy of single skin lesion
  3. Tangential biopsy of additional skin lesion
  4. Punch biopsy of single skin lesion
  5. Destruction of skin growth
  6. Destruction of 2-14 skin growths
  7. Destruction of up to 14 skin growths
  8. Destruction of 15 or more skin growths
  9. Biopsy of lip
  10. Biopsy of ear
  11. Application of light and light-sensitive drugs to aid destruction of premalignant skin growths, per day
  12. Application of light and light-sensitive drugs following removal of premalignant thickened skin growth, per day
  13. New patient office or other outpatient visit, typically 20 minutes
  14. New patient office or other outpatient visit, typically 30 minutes
  15. Established patient office or other outpatient visit, typically 10 minutes
  16. Established patient office or other outpatient visit, typically 15 minutes
  17. Established patient office or other outpatient, visit typically 25 minutes
  18. Injection, triamcinolone acetonide, not otherwise specified, 10 mg
  19. Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg
  20. All potassium hydroxide (koh) preparations

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $8

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788867221

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Immunology

Name of Drug #1: REMICADE

Open Associated Drug #1: 57894-030-01

Drug or Biological: Biological

Product Category #2: Immunology

Name Of Drug #2:: STELARA

Associated Drug #2: 57894-060-03

Drug or Biological #3:: Biological

Product Category #3: Immunology

Name of Drug: SIMPONI ARIA

Name Of Drug #3: 57894-350-01

Drug or Biological: Biological

Product Category #4: Immunology

Name of Drug #4: SIMPONI

Associated Drug #4: 57894-070-01

Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788867223

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Immunology

Name of Drug #1: TREMFYA

Open Associated Drug #1: 57894-640-01

Payments Total: $4

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788867225

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Immunology

Name of Drug #1: TREMFYA

Open Associated Drug #1: 57894-640-01

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest:

Third party is a Charity:: No

Record ID:: 788867227

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Immunology

Name of Drug #1: TREMFYA

Open Associated Drug #1: 57894-640-01

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795003747

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: SKYRIZI

Open Associated Drug #1: 0074-2042-02

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795003739

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: SKYRIZI

Open Associated Drug #1: 0074-2042-02

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 795003743

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: HUMIRA

Open Associated Drug #1: 0074-0554-02

Payments Total: $50

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 814515359

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: COSENTYX

Open Associated Drug #1: 0078-0639-41

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 814515361

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: COSENTYX

Open Associated Drug #1: 0078-0639-41

Payments Total: $34

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 809664775

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: INFLAMMATION AND IMMUNOLOGY

Name of Drug #1: DUPIXENT

Open Associated Drug #1: 0024-5914-01

Nurse Practitioner Professionals in Ottumwa

1.
Peggy Swank

1013 Pennsylvania Ave
Ottumwa, IA
Ottumwa Health Group Llc

2.
Catherine Durflinger

1001 Pennsylvania Ave
Ottumwa, IA
Emergency Services Of Iowa Llc

3.
Jacoby Stieler

1005 Pennsylvania Ave
Ottumwa, IA
Catholic Health Initiatives-iowa Corp

4.
Stacy Walker NP

1001 Pennsylvania Ave
Ottumwa, IA
Emergency Services Of Iowa Llc

5.
Stacy Walker NP

522 N Hancock St
Ottumwa, IA
Mercy Medical Center-centerville

6.
Jean Schmitt NP

1005 Pennsylvania Ave
Ottumwa, IA
Catholic Health Initiatives-iowa Corp

Providers in Forefront Dermatology

1.Kelly Abate Md

1890 Silver Cross Blvd
New Lenox Il 60451-9596
Forefront Dermatology
Dermatology

2.Kelly Abate Md

1520 Bond St
Naperville Il 60563-2358
Forefront Dermatology
Dermatology

3.Craig Abbott

3500 S Western Ave
Oklahoma City Ok 73109-2413
Forefront Dermatology
Dermatology

4.Craig Abbott

2644 Nw 63rd St
Oklahoma City Ok 73116-4902
Forefront Dermatology
Dermatology

5.Sarah Abraham

5500 Corporate Dr
Pittsburgh Pa 15237-5848
Forefront Dermatology
Physician Assistant

6.Sarah Abraham

180 Fort Couch Rd
Pittsburgh Pa 15241-1046
Forefront Dermatology
Physician Assistant

View all 467 members of Forefront Dermatology medical group


Medicared For All
Vote!
Share